Cite
APA Citation
Novello, S., Mazières, J., Oh, I. -., de Castro, J., Migliorino, M. R., Helland, Å., Dziadziuszko, R., Griesinger, F., Kotb, A., Zeaiter, A., Cardona, A., Balas, B., Johannsdottir, H. K., Das-Gupta, A., & Wolf, J. (2018). alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study. Annals of oncology, 29, 1409–1416. http://access.bl.uk/ark:/81055/vdc_100095324268.0x00003b